Rethinking Life Sciences | KPMG | UK

Rethinking Life Sciences

Rethinking Life Sciences

Our insights page offers practical advice for leaders seeking agility, adaptability and fresh ideas in these crucial areas.

Our insights page offers practical advice to leaders seeking fresh ideas.

Welcome to KPMG’s Rethinking Life Sciences insights page, home to our latest thinking about the latest trends and challenges facing pharmaceutical and biotech firms.

Our team encompass a wide range of disciplines – from oncologists and medical researchers to tax specialists and cyber security practioners.

Their insights are as diverse as their backgrounds, delivering to you fresh thinking and insights into the biggest trends defining the sector’s future.

Our insights include:

  • How partnering with patient groups can help mutually beneficial relationships between industry and patient representative bodies to develop
  • A look into how pharma companies can successfully differentiate themselves for long-term profitable growth
  • Exploring the role that big data plays in the life sciences sector

This is only the start of the conversation. Continue it by getting in touch with our team of experts.

Connect with us

Opportunities for efficiency in R&D

Opportunities for efficiency in R&D

Most firms face a challenge of improving returns on investment in pharma R&D. Hasini Wijesuriya explains how they can achieve enhanced R&D efficiency.

Succeeding in a commoditised market

Succeeding in a commoditised market

We look at the US influenza vaccine market and outline how pharma companies can successfully differentiate themselves for long-term profitable growth

Exceptional Women in Life Sciences 2017

This series demonstrates KPMG’s commitment to the development and advancement of women.

 
Read more

Value-based pricing in pharmaceuticals

Value-based pricing is a win-win for the pharmaceuticals sector.

 
Read more

Prescription for change

Pressure on the primary care providers is creating opportunities for pharmacies.

 
Read more

Life sciences’ performance dilemmas

Pharma companies can secure long-term success through optimal performance.

 
Read more